Table 1
From: An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study
A | Â | Â |
|---|---|---|
Baseline characteristics for men. Data are reported as median and range | ||
| Â | Chronic viral hepatitis patients (n = 36) | Control Subjects (n = 17) |
Age (years) | 45.5 (19,73) | 62.5 (21,79) |
Height (cm) | 173 (160,190) | 173 (167,186) |
Weight (kg) | 81.5 (58,118) | 75 (62,100) |
BMI (kg/m 2 ) | 26.3 (20.3,36.2) | 25.1 (21.5, 29.5) |
FMI | 9.99 (5.5, 17.4) | 9.09 (6.39, 12.4) |
Glucose (mg/dl) | 96.5 (70,147)* | 88 (60,183) |
Insulin (μU/mL) | 7.34 (0.73, 125.8) | 9.18 (3.05,17.28) |
HOMA-IR | 2 (0.12–7.36) | 2 (0.88–4.89) |
AST (IU/l) | 59 (19,274)* | 26 (21,35) |
ALT (IU/l) | 105 (24,366)* | 25 (20,36) |
Leptin (pg/ml) | 5134 (695,30430) | 5054 (588,15325) |
B | Â | Â |
Baseline characteristics for women. Data are reported as median and range | ||
| Â | Chronic viral hepatitis patients (n = 14) | Control Subjects (n = 15) |
Age (years) | 38 (16,70) | 51 (20,74) |
Height (cm) | 165 (156,169) | 160 (153,168) |
Weight (kg) | 77 (51,112) | 74 (60,94) |
BMI (kg/m 2 ) | 29.7 (18,39.3) | 29.5 (23.1,38.8) |
FMI | 12.6 (3.81,19.7) | 12.4 (7.59,17.39) |
Glucose (mg/dl) | 80.5 (70,175) | 81 (60,156) |
Insulin (μU/mL) | 5.65 (0.73,16.47) | 8.43 (5.67,67.76) |
HOMA-IR | 1.02 (0.12, 6.25) | 1.53 (0.95–13.5) |
AST (IU/l) | 55 (38,129)* | 27 (20,35) |
ALT (IU/l) | 66 (54,269)* | 27 (21,32) |
Leptin (pg/ml) | 11372(1714,43605) | 18990(4876,48928) |